(secondQuint)Lacripep in Subjects With Dry Eye Associated With Primary Sjgren's Syndrome.

 This is a multi-center, randomized, placebo-controlled, double-masked, parallel-group study.

 Subjects will be randomized into three treatment groups: 0.

005%, or 0.

01% Lacripep cent , or placebo in a 1:1:1 ratio.

.

 Lacripep in Subjects With Dry Eye Associated With Primary Sjgren's Syndrome@highlight

The objective of this study is to evaluate the efficacy and safety of two strengths of Lacripep cent ophthalmic solution versus placebo administered three times daily for four weeks in subjects with a diagnosis of Dry Eye associated with documented Primary Sjogren's Syndrome